Incidence of anaphylaxis to sugammadex in a single-center cohort of 19,821 patients

MA Burbridge - Anesthesia & Analgesia, 2021 - journals.lww.com
Background: Sugammadex is a modified cyclodextrin that is being increasingly used in
anesthetic practice worldwide for the reversal of the aminosteroid neuromuscular blockers …

Incidence of Anaphylaxis to Sugammadex in a Single-Center Cohort of 19,821 Patients

MA Burbridge - Anesthesia & Analgesia, 2021 - journals.lww.com
Background: Sugammadex is a modified cyclodextrin that is being increasingly used in
anesthetic practice worldwide for the reversal of the aminosteroid neuromuscular blockers …

Incidence of Anaphylaxis to Sugammadex in a Single-Center Cohort of 19,821 Patients

MA Burbridge - Anesthesia and analgesia, 2021 - pubmed.ncbi.nlm.nih.gov
Background Sugammadex is a modified cyclodextrin that is being increasingly used in
anesthetic practice worldwide for the reversal of the aminosteroid neuromuscular blockers …

Incidence of Anaphylaxis to Sugammadex in a Single-Center Cohort of 19,821 Patients

MA Burbridge - Anesthesia & Analgesia, 2020 - ingentaconnect.com
Background: Sugammadex is a modified cyclodextrin that is being increasingly used in
anesthetic practice worldwide for the reversal of the aminosteroid neuromuscular blockers …

Incidence of Anaphylaxis to Sugammadex in a Single-Center Cohort of 19,821 Patients.

MA Burbridge - Anesthesia and Analgesia, 2021 - europepmc.org
Background Sugammadex is a modified cyclodextrin that is being increasingly used in
anesthetic practice worldwide for the reversal of the aminosteroid neuromuscular blockers …